SUNESIS PHARMACEUTICALS

sunesis-pharmaceuticals-logo

Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.

#SimilarOrganizations #People #Financial #Website #More

SUNESIS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1998-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.sunesis.com

Total Employee:
51+

Status:
Active

Contact:
650) 266-3500

Email Addresses:
[email protected]

Total Funding:
171.7 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail ReCAPTCHA Cloudflare Hosting Cloudflare DNS ReCAPTCHA V2 Internap Thomson Reuters Corporate Solutions


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

victoria-saucier_image

Victoria Saucier Investor @ Sunesis Pharmaceuticals
Board_member

matthew-fust_image

Matthew Fust Board of Directors @ Sunesis Pharmaceuticals
Board_member

ed-hurwitz_image

Ed Hurwitz Board of Directors @ Sunesis Pharmaceuticals
Board_member

not_available_image

David Stump Board of Directors @ Sunesis Pharmaceuticals
Board_member

steve-carchedi_image

Steve Carchedi Board of Directors @ Sunesis Pharmaceuticals
Board_member
2013-01-01

dayton-misfeldt_image

Dayton Misfeldt Board of Directors @ Sunesis Pharmaceuticals
Board_member

Current Employees Featured

william-p-quinn_image

William P. Quinn
William P. Quinn Chief Financial Officer and Senior Vice President, Finance and Corporate Development @ Sunesis Pharmaceuticals
Chief Financial Officer and Senior Vice President, Finance and Corporate Development

tina-gullotta_image

Tina Gullotta
Tina Gullotta Vice President, Finance and Principal Accounting Officer @ Sunesis Pharmaceuticals
Vice President, Finance and Principal Accounting Officer

pietro-taverna_image

Pietro Taverna
Pietro Taverna Vice President, Translational Medicine & Nonclinical Development @ Sunesis Pharmaceuticals
Vice President, Translational Medicine & Nonclinical Development

judy-fox_image

Judy Fox
Judy Fox Chief Scientific Officer @ Sunesis Pharmaceuticals
Chief Scientific Officer

deepali-suri_image

Deepali Suri
Deepali Suri Vice President, Clinical Operations @ Sunesis Pharmaceuticals
Vice President, Clinical Operations

dayton-misfeldt_image

Dayton Misfeldt
Dayton Misfeldt Interim Chief Executive Officer @ Sunesis Pharmaceuticals
Interim Chief Executive Officer

mehdi-paborji_image

Mehdi Paborji
Mehdi Paborji Vice President, Technical Operations @ Sunesis Pharmaceuticals
Vice President, Technical Operations

parvinder-hyare_image

Parvinder Hyare
Parvinder Hyare Head of Global Oncology Operations @ Sunesis Pharmaceuticals
Head of Global Oncology Operations
2015-01-01

james-w-young_image

James W. Young
James W. Young Non-Executive Chairman @ Sunesis Pharmaceuticals
Non-Executive Chairman
2000-01-01

Founder


james-wells_image

James Wells

Stock Details


Company's stock symbol is NASDAQ:SNSS

Investors List

bridge-bank_image

Bridge Bank

Bridge Bank investment in Post-IPO Debt - Sunesis Pharmaceuticals

caxton-advantage-life-sciences-fund_image

Caxton Advantage Life Sciences Fund

Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - Sunesis Pharmaceuticals

opuspoint-partners_image

OpusPoint Partners

OpusPoint Partners investment in Post-IPO Equity - Sunesis Pharmaceuticals

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Post-IPO Equity - Sunesis Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Post-IPO Equity - Sunesis Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Sunesis Pharmaceuticals

merlin-nexus_image

Merlin Nexus

Merlin Nexus investment in Post-IPO Equity - Sunesis Pharmaceuticals

vision-capital-advisors_image

Vision Capital Advisors

Vision Capital Advisors investment in Post-IPO Equity - Sunesis Pharmaceuticals

venrock_image

Venrock

Venrock investment in Post-IPO Equity - Sunesis Pharmaceuticals

nextech-invest_image

Nextech Invest

Nextech Invest investment in Post-IPO Equity - Sunesis Pharmaceuticals

Official Site Inspections

http://www.sunesis.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 76.223.54.146
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Sunesis Pharmaceuticals" on Search Engine